CefiximeThird Party Manufacturing in India

Cefixime works by disrupting the formation of bacterial cell walls, leading to the destruction of the bacteria.

It binds to penicillin-binding proteins (PBPs) inside the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This structural compromise causes the bacterial cell to lyse and die, which rapidly alleviates the infection and helps the body recover.

Unlike earlier generation cephalosporins, Cefixime exhibits enhanced stability against beta-lactamase enzymes produced by many resistant bacteria. It is highly effective and well-tolerated for patients battling stubborn respiratory and genitourinary infections.

Therapeutic Uses

Cefixime is prescribed for the treatment of:

• Respiratory Tract Infections: Used for treating acute exacerbations of chronic bronchitis and pharyngitis.
• Urinary Tract Infections: Highly effective in managing uncomplicated urinary tract infections.
• Ear Infections: A reliable choice for treating acute otitis media in children.
• Sexually Transmitted Infections: Prescribed for uncomplicated gonorrhea.

Why Manufacturers Choose Cefixime

Cefixime is a highly robust molecule with broad-spectrum activity, particularly against beta-lactamase producing organisms. The Indian pharmaceutical market sees massive demand for oral third-generation cephalosporins due to their reliable clinical outcomes and prescription volumes.

This makes Cefixime one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies looking for WHO-GMP certified manufacturing capabilities.